Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
Sign up today and learn more about Trigemina Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Trigemina Stock
Chief Medical Officer
William Frey II
Chief Medical Advisor
Founder, Chief Scientist
David C Yeomans
Chief Financial Officer & Chief Operating Officer